ArticleNature communications2026
Author Correction: The human ciliopathy protein RSG1 links the CPLANE complex to transition zone architecture.
Abstract readPublished Erratum
In one paragraph
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
30 authors.
Neftalí Vazquez *Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, USA.
Chanjae Lee *Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, USA.
Irene Valenzuela *Department of Pediatrics, Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0003-2350-6058
Thao P PhanDepartment of Biochemistry and Biophysics, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA.
Camille DerderianDepartment of Biochemistry and Biophysics, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-3727-0242
Marcelo ChávezBaxter Laboratory, Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Nancie A MooneyBaxter Laboratory, Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Janos DemeterBaxter Laboratory, Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-7301-8055
Mohammad Ovais Aziz-ZanjaniBaxter Laboratory, Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Ivon CuscoDepartment of Clinical and Molecular Genetics, Vall d´Hebron University Hospital. European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability (ERN-ITHACA), Medicine Genetics Group, Vall d´Hebron Research Institute, Barcelona, Spain.
Marta CodinaDepartment of Clinical and Molecular Genetics, Vall d´Hebron University Hospital. European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability (ERN-ITHACA), Medicine Genetics Group, Vall d´Hebron Research Institute, Barcelona, Spain.
Núria Martínez-GilDepartment of Clinical and Molecular Genetics, Vall d´Hebron University Hospital. European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability (ERN-ITHACA), Medicine Genetics Group, Vall d´Hebron Research Institute, Barcelona, Spain.
Diana ValverdeCINBIO, University of Vigo and Research Group on Rare Diseases and Pediatric Medicine, Health Research Institute Galicia Sur (IIS Galicia Sur), SERGASUVIGO, Vigo, Spain.
Carlos SolaratCINBIO, University of Vigo and Research Group on Rare Diseases and Pediatric Medicine, Health Research Institute Galicia Sur (IIS Galicia Sur), SERGASUVIGO, Vigo, Spain.
Ange-Line BruelFunctional Unity of Innovative Diagnosis for Rare Diseases and Inserm UMR1231 team GAD, University of Burgundy, Dijon, France.ORCID http://orcid.org/0000-0002-0526-465X
Cristel Thauvin-RobinetFunctional Unity of Innovative Diagnosis for Rare Diseases and Inserm UMR1231 team GAD, University of Burgundy, Dijon, France.ORCID http://orcid.org/0000-0002-4155-139X
Elisabeth SteichenDepartment of Pediatrics, Medical School, University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0001-9949-7202
Isabel FilgesMedical Genetics, Institute of Medical Genetics and Pathology and Department of Clinical Research, University Hospital Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-2149-6354
Pascal JosetMedical Genetics, Institute of Medical Genetics and Pathology and Department of Clinical Research, University Hospital Basel, Basel, Switzerland.
Julie De GeyterMedical Genetics, Institute of Medical Genetics and Pathology and Department of Clinical Research, University Hospital Basel, Basel, Switzerland.
Krishna VaidyanathanDepartment of Molecular Biosciences, University of Texas at Austin, Austin, TX, USA.
Tynan P GardnerDepartment of Molecular Biosciences, University of Texas at Austin, Austin, TX, USA.
Michinori ToriyamaDepartment of Biomedical Sciences, School of Biological and Environmental Sciences, Kwansei Gakuin University, Sanda, Hyogo, Japan.
Edward M MarcotteDepartment of Molecular Biosciences, University of Texas at Austin, Austin, TX, USA.ORCID http://orcid.org/0000-0001-8808-180X
Kevin DrewDepartment of Biological Sciences, University of Illinois at Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-1260-4413
Elle C RobersonDevelopmental Biology and Pediatrics, CU Anschutz Medical Campus, Aurora, CO, USA.
Peter K JacksonBaxter Laboratory, Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-1742-2539
Jeremy F ReiterDepartment of Biochemistry and Biophysics, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-6512-320X
Eduardo F Tizzano *Department of Clinical and Molecular Genetics, Vall d´Hebron University Hospital. European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability (ERN-ITHACA), Medicine Genetics Group, Vall d´Hebron Research Institute, Barcelona, Spain. eduardo.tizzano@vallhebron.cat.
John B Wallingford *Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, USA. wallingford@utexas.edu.ORCID http://orcid.org/0000-0002-6280-8625
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.